Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Total Debt (2021 - 2023)

Historic Total Debt for Pulse Biosciences (PLSE) over the last 3 years, with Q1 2023 value amounting to $65.0 million.

  • Pulse Biosciences' Total Debt changed N/A to $65.0 million in Q1 2023 from the same period last year, while for Mar 2023 it was $65.0 million, marking a year-over-year change of. This contributed to the annual value of $65.0 million for FY2022, which is N/A changed from last year.
  • Per Pulse Biosciences' latest filing, its Total Debt stood at $65.0 million for Q1 2023.
  • Pulse Biosciences' Total Debt's 5-year high stood at $65.0 million during Q3 2022, with a 5-year trough of $41.0 million in Q1 2021.
  • For the 3-year period, Pulse Biosciences' Total Debt averaged around $59.0 million, with its median value being $65.0 million (2022).